CTXblood test normal range The CTX peptide, specifically the C-terminal telopeptide of type I collagen (often referred to as CTx or beta-CTX), is a crucial biochemical marker that provides insights into bone resorption. This protein fragment is released into the bloodstream during the breakdown of mature bone, making it a valuable tool for assessing bone turnover and monitoring conditions related to bone health. Understanding CTX levels can help clinicians and patients alike evaluate the rate at which bone is being lost and the effectiveness of treatments aimed at slowing this process.
CTX peptide is a component of type I collagen, which constitutes approximately 90% of the organic matrix of bone. When bone is resorbed by osteoclasts, fragments of this collagen, including the C-terminal telopeptide, are released into circulationBIOPHYSICAL CHARACTERIZATION OF Ctx(Ile21)-Ha .... Elevated levels of CTX in the serum are indicative of increased bone resorption, a process that can lead to conditions such as osteoporosis and osteopenia. Conversely, a decrease in CTX levels often signifies a reduction in bone breakdown, which is a desired outcome when treating these diseases.
The importance of CTX as a biomarker is further highlighted by its role in monitoring therapeutic interventions.Human CTX-I ELISA Kit For instance, antiresorptive therapies like bisphosphonates and hormone replacement therapy aim to reduce bone resorption. Measuring CTX levels before and during treatment can help determine if the therapy is effectively slowing down bone loss.
* Origin: Derived from the breakdown of type I collagen in bone.
* Function: A marker of bone resorption activity.Test Definition: CTX
* Clinical Significance: Used to assess bone loss, diagnose metabolic bone diseases, and monitor treatment efficacy for conditions like osteoporosis.
* Measurement: Typically measured in serum through various assay kits.Cerebrotendinous Xanthomatosis (CTX) - Cedars-Sinai
The delicate balance between bone formation and bone resorption is essential for maintaining skeletal integrity.2025年6月2日—Determination of the C terminal telopeptides in serum is recommeded for monitoring the efficacy of antiresorptive therapies (eg bisphosphonates or hormone ... When resorption outpaces formation, net bone loss occurs, increasing the risk of fracturesThe RatLaps™ (CTX-I) EIA is based upon the competitive binding of a polyclonal antibody to soluble RatLaps antigens EKSQDGGR or to immobilised RatLaps antigens.. CTX peptide plays a vital role in reflecting this imbalance.
Osteoporosis is characterized by low bone mass and structural deterioration of bone tissue, leading to increased fragility and susceptibility to fractures. In individuals with osteoporosis, osteoclast activity is often heightened, resulting in elevated CTX levels. Monitoring these levels can help identify individuals at higher risk of fracture, particularly postmenopausal women, where hormonal changes can accelerate bone loss.
For patients undergoing treatment for osteoporosis or other metabolic bone diseases, CTX measurements are invaluable. A successful antiresorptive therapy should lead to a reduction in CTX levels over time, indicating that the rate of bone breakdown is decreasing. This allows healthcare providers to adjust treatment strategies as needed and ensure optimal outcomes.
Beyond osteoporosis, CTX can also be useful in assessing bone turnover in other metabolic bone diseases where bone resorption is altered. Its ability to reflect rapid bone breakdown makes it a versatile marker in endocrinology and rheumatology.
Various laboratory assays are available to measure CTX peptide levels, with serum CTX assays being the most common.CTX-I elisa kit | Human Cross-linked Carboxy-terminal ... These tests typically quantify specific forms of the C-terminal telopeptide, such as beta-CTX (β-CTX).
Interpreting CTX test results requires consideration of several factors, including age, sex, menopausal status, and the specific laboratory's reference ranges. Generally, higher CTX levels indicate greater bone resorption作者：CYS Lee·2010·被引用次数：113—Serum cross-linked C-telopeptide of type I collagen (CTX)is a marker of osteoclast activityand is used to assess the level of bone resorption. Recently, in .... For example, elevated levels are often observed in conditions like Paget's disease and hyperparathyroidism, alongside osteoporosisHuman CTXⅠ(Cross Linked C-telopeptide of Type Ⅰ Collagen) ELISA Kit (E-EL-H0835) ; Sample Volume, 100 μL ; Total Assay Time, 3 h 30 min ; Reactivity, Human..
Reference ranges for CTX can vary between laboratories, and it is crucial to use the ranges provided by the facility where the test was performed. Factors such as diurnal variation (levels can be slightly higher in the morning) and the presence of certain medications can also influence CTX levels.
While its primary role is in assessing bone metabolism, research has explored CTX in other contexts. For instance, there are mentions of CTX-II, which relates to type II collagen found in cartilage, suggesting potential applications in assessing cartilage degradation. Additionally, some studies have investigated specific peptide sequences related to CTX for potential antimicrobial or other biological activities, though these are distinct from the clinical use of CTX as a bone biomarker.
The CTX peptide stands as a critical biomarker in understanding and managing bone health.This Human CTX-I ELISA Kit was designed for the quantitative measurement ofHuman CTX-I proteinin serum, plasma, tissue homogenates. By accurately reflecting the rate of bone resorption, it empowers clinicians to diagnose conditions like osteoporosis, assess fracture risk, and effectively monitor the impact of therapeutic interventions. As research continues, the comprehensive understanding of CTX and its variations will undoubtedly further refine its clinical utility in preserving skeletal strength and overall well-beingCollagen Type I C-Telopeptide (CTx) | Test Detail.
Join the newsletter to receive news, updates, new products and freebies in your inbox.